TBRG
TruBridge, Inc. Common Stock · Healthcare · Health Information Services
Last
$26.24
$0.00 (0.00%) 4:00 PM ET
After hours $26.24 $0.00 (0.00%) 10:08 PM ET
Prev close $26.24
Open $26.24
Day high $26.25
Day low $26.24
Volume 270,395
Avg vol 282,383
P/E ratio
0.00
FY Revenue
$110.86M
EPS
4,166,830.41
Gross Margin
57.27%
Sector
Healthcare
AI report sections
TBRG
TruBridge, Inc. Common Stock
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
−27% (Below avg)
Vol/Avg: 0.73×
RSI
80.37 (Overbought)
Overbought (>70)
MACD momentum
Intraday
-0.00 (Weak)
MACD: -0.00 Signal: 0.00
Short-Term
-0.03 (Weak)
MACD: 0.14 Signal: 0.18
Long-Term
-0.07 (Weak)
MACD: 0.63 Signal: 0.70
Intraday trend score 49.00

Latest news

TBRG 12 articles Positive: 0 Neutral: 0 Negative: 12
Negative GlobeNewswire Inc. • The Rosen Law Firm
TruBridge Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

TruBridge, Inc. (NASDAQ: TBRG) is facing a securities class action investigation after filing a late notification on March 17, 2026, revealing material errors in previously issued financial statements for 2023, 2024, and 2025. The errors involved revenue recognition, stock-based compensation, and capitalized software development expenses. The stock fell 10.5% to $15.75 per share following the announcement. The Rosen Law Firm is seeking compensation for affected shareholders.

TBRG securities class action financial statement errors revenue recognition stock price decline investor losses Form 12b-25 out-of-period errors
Sentiment note

Company disclosed material errors in previously issued financial statements spanning multiple years, resulting in a 10.5% stock price decline and triggering a securities class action lawsuit. The restatement of revenues, expenses, and compensation across 2023-2025 indicates significant accounting failures and loss of investor confidence.

Negative GlobeNewswire Inc. • Rosen Law Firm
AVAV IMPORTANT DEADLINE: ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages AeroVironment, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AVAV

Rosen Law Firm announces securities class action lawsuits against AeroVironment, Futu Holdings Limited, and TruBridge, Inc. AeroVironment is accused of making false statements about competition risks related to U.S. Space Force contracts. Investors with losses exceeding $100,000 are encouraged to join the class actions before the July 27, 2026 lead plaintiff deadline.

AVAV FUTU TBRG securities class action AeroVironment Futu Holdings TruBridge investor losses
Sentiment note

Under investigation by Rosen Law Firm for potential securities claims on behalf of shareholders, indicating alleged violations and investor losses.

Negative GlobeNewswire Inc. • Halper Sadeh Llc
Halper Sadeh LLC is Investigating Whether DAN, ROKU, TBRG, AFBI are Obtaining Fair Deals for their Shareholders

Investor rights law firm Halper Sadeh LLC is investigating four proposed mergers and acquisitions to determine if shareholders are receiving fair deals. The investigations focus on Dana Incorporated's sale to Eaton Corporation, Roku's acquisition by Fox Corporation, TruBridge's sale to Inventurus Knowledge Solutions, and Affinity Bancshares' merger with Fidelity BancShares. The firm is examining potential securities law violations and fiduciary duty breaches, particularly regarding insider benefits and terms that may limit competing offers.

DAN ROKU TBRG AFBI M&A investigation shareholder rights fiduciary duty securities law
Sentiment note

Under investigation for potential violations in its sale to Inventurus Knowledge Solutions; shareholders may not be receiving optimal deal terms

Negative GlobeNewswire Inc. • Rosen Law Firm
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Roblox Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – RBLX

Rosen Law Firm is encouraging investors who purchased shares of Roblox Corporation between October 30, 2025 and April 30, 2026 to join a securities class action lawsuit. The firm alleges that Roblox made materially false and misleading statements regarding its organic growth potential, concealing that enrollment in age verification would cause significant growth slowdown, reduced app store ratings, and diminished organic growth. The lead plaintiff deadline is August 7, 2026. The firm is also investigating potential securities claims for Embecta Corp. and TruBridge, Inc.

RBLX EMBC TBRG securities class action investor lawsuit material misstatement organic growth age verification
Sentiment note

Company is under investigation by Rosen Law Firm for potential securities claims on behalf of shareholders, indicating alleged investor harm.

Negative GlobeNewswire Inc. • The Rosen Law Firm
TruBridge Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

TruBridge, Inc. (NASDAQ: TBRG) filed a late filing notification on March 17, 2026, revealing material errors in previously issued financial statements for fiscal years 2023-2025. The errors involved revenue recognition, stock-based compensation, and capitalized software development expenses, causing the stock to fall 10.5% to $15.75 per share. The Rosen Law Firm is investigating potential securities claims and preparing a class action lawsuit on behalf of affected shareholders.

TBRG financial statement errors revenue recognition securities class action Form 12b-25 stock price decline investor losses out-of-period errors
Sentiment note

Company disclosed material errors in previously issued financial statements spanning multiple years and quarters, resulting in a 10.5% stock price decline and triggering a securities class action investigation. The errors indicate potential mismanagement and loss of investor confidence.

Negative GlobeNewswire Inc. • Brodsky & Smith
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)

Brodsky & Smith law firm has announced investigations into multiple merger transactions, including Apogee Therapeutics (acquired by AbbVie for $135.11/share), Roku (acquired by Fox for $160/share), TruBridge (acquired by Inventurus for $26.25/share), and Organon (acquired by Sun Pharmaceutical for $14/share). The investigations focus on whether the respective boards breached fiduciary duties by failing to conduct fair processes and whether deal consideration provides fair value to shareholders.

APGE ABBV ROKU FOX merger investigation fiduciary duty shareholder litigation deal valuation
Sentiment note

Under investigation for potential board breach of fiduciary duties regarding merger fairness and deal consideration adequacy

Negative GlobeNewswire Inc. • Rosen Law Firm
חדשות למשקיעים ב-TruBridge: אם סבלתם הפסדים ב-TruBridge, Inc (נאסד"ק: TBRG), אתם מוזמנים ליצור קשר עם משרד רוזן עורכי הדין רוזן בנוגע לזכויותיכם

TruBridge, Inc. (NASDAQ: TBRG) is facing a potential securities class action lawsuit after disclosing accounting errors in previously published financial statements. The company identified errors in revenue recognition, contract costs, stock-based compensation, and capitalized software development expenses across multiple fiscal periods. Following the announcement on March 17, 2026, the stock declined 10.5% to $15.75 per share. Rosen Law Firm is investigating claims on behalf of affected shareholders.

TBRG accounting errors securities class action financial restatement investor losses revenue recognition stock decline
Sentiment note

Company disclosed material accounting errors spanning multiple years and quarters, requiring financial restatement. Stock price declined 10.5% following the announcement, and the company faces a securities class action lawsuit alleging misleading disclosure to investors.

Negative GlobeNewswire Inc. • The Rosen Law Firm
TruBridge Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. after the company filed a late filing notification on March 17, 2026, disclosing material errors in previously issued financial statements for 2023-2025. The errors involved revenue recognition, stock-based compensation, and capitalized software development expenses. TruBridge's stock fell 10.5% on the announcement. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

TBRG securities class action financial restatement revenue recognition errors stock price decline investor losses Form 12b-25 out-of-period errors
Sentiment note

Company disclosed material errors in previously issued financial statements spanning multiple years (2023-2025), resulting in a 10.5% stock price decline and triggering a securities class action investigation. The restatement involves significant accounting issues including revenue recognition and expense classification errors.

Negative GlobeNewswire Inc. • Halper Sadeh Llc
Halper Sadeh LLC is Investigating Whether SLP, ROKU, TBRG are Obtaining Fair Deals for their Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating three companies for potential violations of federal securities laws and breaches of fiduciary duties. The investigations concern Simulations Plus' sale to Altaris for $18.50 per share, Roku's sale to Fox Corporation for $96.00 cash plus 0.9693 Fox shares per share, and TruBridge's sale to Inventurus Knowledge Solutions for $26.25 per share. The firm is seeking increased consideration, additional disclosures, and other relief on behalf of shareholders.

SLP ROKU TBRG merger investigation shareholder rights fiduciary duty securities law acquisition
Sentiment note

Company is under investigation for potential securities law violations and breach of fiduciary duties related to its acquisition, suggesting shareholders may not be receiving fair consideration.

Negative GlobeNewswire Inc. • Brodsky & Smith
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG), Organon & Co. (NYSE – OGN)

Brodsky & Smith law firm is investigating four merger transactions to determine whether company boards breached fiduciary duties by failing to conduct fair processes and provide fair value to shareholders. The investigations involve Simulations Plus ($18.50/share), Roku ($160.00/share), TruBridge ($26.25/share), and Organon ($14.00/share).

SLP ROKU TBRG OGN merger investigation fiduciary duty shareholder litigation fair value
Sentiment note

Under investigation for potential board breach of fiduciary duties regarding fair process and fair value in acquisition by Inventurus Knowledge Solutions for $26.25/share

Negative GlobeNewswire Inc. • Rosen Law Firm
RGC DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC

Rosen Law Firm announces securities class action lawsuits against Regencell Bioscience Holdings Limited, Sportradar Group AG, and TruBridge, Inc. Investors with losses exceeding $100,000 are encouraged to join the litigation before the June 23, 2026 deadline. The lawsuits allege false and misleading statements regarding market manipulation, regulatory risks, and undisclosed material information.

RGC SRAD TBRG securities class action investor losses market manipulation regulatory scrutiny lead plaintiff deadline
Sentiment note

Company is subject to ongoing investigation for potential securities claims on behalf of shareholders who have suffered losses.

Negative GlobeNewswire Inc. • Rosen Law Firm
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Disc Medicine (IRON), TruBridge (TBRG), and PennyMac Financial Services (PFSI) for allegedly issuing materially misleading business information. Disc Medicine's stock fell 22% on February 13, 2026, following an FDA Complete Response Letter rejecting its bitopertin program NDA. Investors who suffered losses are encouraged to join prospective class action lawsuits.

IRON TBRG PFSI securities fraud class action lawsuit FDA rejection investor losses Complete Response Letter
Sentiment note

Company is subject to securities fraud investigation by Rosen Law Firm for allegedly issuing materially misleading business information to investors.

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal